Lee Ainslie Cooper Companies, Inc. Transaction History

Maverick Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$323.56 - $373.36 $567,524 - $654,873	1,754 New	1,754 $654,000
Q4 2020 Feb 16, 2021	SELL	$319.05 - $363.32 $454,327 - $517,367	-1,424 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$280.08 - $347.78 $650,625 - $807,892	-2,323 Reduced 62.0%	1,424 $480,000
Q2 2020 Aug 14, 2020	SELL	$270.93 - $320.3 $905,448 - $1.07 Million	-3,342 Reduced 47.14%	3,747 $1.06 Million
Q1 2020 May 15, 2020	BUY	$243.44 - $359.98 $177,224 - $262,065	728 Added 11.44%	7,089 $1.95 Million
Q4 2019 Feb 14, 2020	BUY	$281.18 - $322.05 $763,966 - $875,009	2,717 Added 74.56%	6,361 $2.04 Million
Q3 2019 Nov 14, 2019	BUY	$294.25 - $341.49 $1.07 Million - $1.24 Million	3,644 New	3,644 $1.08 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.